|
ZNF813 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.803800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.400800E-01 |
| Normal-vs-Stage2 |
2.640800E-01 |
| Normal-vs-Stage3 |
8.701800E-02 |
| Normal-vs-Stage4 |
5.394200E-04 |
| Stage1-vs-Stage2 |
7.913800E-01 |
| Stage1-vs-Stage3 |
4.368200E-01 |
| Stage1-vs-Stage4 |
2.439600E-03 |
| Stage2-vs-Stage3 |
7.701400E-01 |
| Stage2-vs-Stage4 |
5.053700E-02 |
| Stage3-vs-Stage4 |
5.433900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.352400E-01 |
| Normal-vs-AfricanAmerican |
2.344200E-01 |
| Normal-vs-Asian |
5.542500E-02 |
| Caucasian-vs-AfricanAmerican |
4.948000E-01 |
| Caucasian-vs-Asian |
4.370400E-01 |
| AfricanAmerican-vs-Asian |
6.048200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.141800E-02 |
| Normal-vs-Female |
3.001800E-01 |
| Male-vs-Female |
1.515630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.331800E-01 |
| Normal-vs-Extreme_Weight |
1.216220E-02 |
| Normal-vs-Obese |
3.102600E-01 |
| Normal-vs-Extreme_Obese |
8.896800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.089800E-01 |
| Normal_Weight-vs-Obese |
8.720000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.020400E-01 |
| Extreme_Weight-vs-Obese |
1.854000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.352200E-01 |
| Obese-vs-Extreme_Obese |
7.568600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.638200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.917000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.972440E-01 |
| Normal-vs-Age(81-100Yrs) |
6.553900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.351200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.710400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.189400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.887600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.968600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.298600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.933700E-02 |
| Normal-VS-Type2 PRCC |
2.893600E-01 |
| Normal-VS-KIRP CIMP |
7.680400E-01 |
| Normal-VS-Unclassified PRCC |
5.050600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.156800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.840400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.279360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.416200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.802410E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.365000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.834000E-02 |
| Normal-vs-N1 |
8.039200E-01 |
| Normal-vs-N2 |
4.355600E-03 |
| N0-vs-N1 |
4.486200E-01 |
| N0-vs-N2 |
2.096200E-01 |
| N1-vs-N2 |
1.792080E-02 |
|
|
